Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
D000293:Adolescent; D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use*
D003520:Cyclophosphamide; D011239:Prednisolone